Evidence Growing That Drug Counterfeiters Are Targeting Generics In The EU
This article was originally published in The Pink Sheet Daily
Counterfeit omeprazole has been found for the third time in Germany, suggesting that the generics sector must raise its game to combat this phenomenon.
You may also be interested in...
The annual German prescription report suggests an additional €4.6 billion can be cut from the country’s annual drug expenditures, which could cause the government to extend its temporary price moratorium and mandatory rebate, as well as pursue other cost-cutting measures.
Although only 12 cases have been reported to the company, extensive use of the anti-platelet drug and shortfalls in adverse event reporting systems mean the number could rise.
European pharma trade federation issues a tender for its product coding system to fight counterfeits, as part of effort to convince the European Commission that a stakeholder-run initiative will work best.